{
    "title": "107_s409",
    "content": "The Act may be cited as the \"Persian Gulf War Illness Compensation Act of 2001\". It includes findings related to the Persian Gulf War. Many veterans of the Persian Gulf War have experienced unexplained illnesses, potentially due to exposure to various biological and chemical agents during the war. These illnesses include chronic fatigue, muscle and joint pain, loss of concentration, forgetfulness, headache, and rash. The Persian Gulf War Veterans' Benefits Act provides compensation for veterans with chronic disabilities resulting from undiagnosed illnesses. Regulations limit compensation to veterans with illnesses that have no known clinical diagnosis. The National Academy of Sciences recommended that the Secretary of Veterans Affairs consider the health effects associated with exposures to specific agents in the Persian Gulf War when developing a compensation program for veterans. The National Academy of Sciences recommended that the Secretary of Veterans Affairs consider health effects from Persian Gulf War exposures when compensating veterans with certain illnesses. The National Academy of Sciences recommended that the Secretary of Veterans Affairs consider health effects from Persian Gulf War exposures when compensating veterans with certain illnesses. The Presumptive Period for Undiagnosed Illnesses Program under title 38, United States Code, is amended to include a definition of 'undiagnosed illness' and extend the deadline for claims. The Presumptive Period for Undiagnosed Illnesses Program is amended to include a list of signs and symptoms that may be manifestations of an undiagnosed illness, such as fatigue, rashes, headache, muscle and joint pain, neurological and neuropsychological symptoms, respiratory issues, sleep disturbances, gastrointestinal and cardiovascular symptoms, abnormal weight loss, and menstrual disorders. The Presumptive Period for Undiagnosed Illnesses Program is amended to include signs and symptoms like fatigue, rashes, headache, muscle and joint pain, neurological symptoms, respiratory issues, sleep disturbances, gastrointestinal and cardiovascular symptoms, abnormal weight loss, and menstrual disorders. Amendments to sections 1117 and 1118 of title 38, United States Code, will take effect on specific dates. The amendments made by this section regarding compensation awards will not be subject to certain limitations if the application is made within one year of the enactment of the Act."
}